Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

47 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Daunorubicin (NSC-83142) versus daunorubicin plus prednisone (NSC-10023) versus daunorubicin plus vincristine (NSC-67574) plus prednisone in advanced childhood acute lymphocytic leukemia.
Jones B, Cuttner J, Levy RN, Patterson RB, Kung F, Pleuss HJ, Falkson G, Treat CL, Haurani F, Burgert EO Jr, Rosner F, Carey RW, Lukens J, Blom J, Degnan TJ, Wohl H, Glidewell O, Holland JF. Jones B, et al. Among authors: levy rn. Cancer Chemother Rep. 1972 Dec;56(6):729-37. Cancer Chemother Rep. 1972. PMID: 4574054 Clinical Trial. No abstract available.
Treatment of adult leukemia with L-asparaginase (NSC-109229).
Onuma T, Rosner F, Levy RN, Cuttner J, Moon JH, Silver RT, Blom J, Falkson G, Burningham R, Glidewell O, Holland JF. Onuma T, et al. Among authors: levy rn. Cancer Chemother Rep. 1971 Jun;55(3):269-75. Cancer Chemother Rep. 1971. PMID: 5315678 No abstract available.
Daunorubicin in the therapy of acute granulocytic leukemia.
Weil M, Glidewell OJ, Jacquillat C, Levy R, Serpick AA, Wiernik PH, Cuttner J, Hoogstraten B, Wasserman L, Ellison RR, Gailani S, Brunner K, Silver RT, Rege VB, Cooper MR, Lowenstein L, Nissen NI, Haurani F, Blom J, Boiron M, Bernard J, Holland JF. Weil M, et al. Cancer Res. 1973 May;33(5):921-8. Cancer Res. 1973. PMID: 4512953 No abstract available.
Comparative study of cytosine arabinoside therapy alone and combined with thioguanine, mercaptopurine, or daunorubicin in acute myelocytic leukemia.
Carey RW, Ribas-Mundo M, Ellison RR, Glidewell O, Lee ST, Cuttner J, Levy RN, Silver R, Blom J, Haurani F, Spurr CL, Harley JB, Kyle R, Moon JH, Eagan RT, Holland JH. Carey RW, et al. Among authors: levy rn. Cancer. 1975 Nov;36(5):1560-6. doi: 10.1002/1097-0142(197511)36:5<1560::aid-cncr2820360504>3.0.co;2-5. Cancer. 1975. PMID: 1059499 Clinical Trial.
Cytosine arabinoside with daunorubicin or adriamycin for therapy of acute myelocytic leukemia: a CALGB study.
Yates J, Glidewell O, Wiernik P, Cooper MR, Steinberg D, Dosik H, Levy R, Hoagland C, Henry P, Gottlieb A, Cornell C, Berenberg J, Hutchison JL, Raich P, Nissen N, Ellison RR, Frelick R, James GW, Falkson G, Silver RT, Haurani F, Green M, Henderson E, Leone L, Holland JF. Yates J, et al. Blood. 1982 Aug;60(2):454-62. Blood. 1982. PMID: 6953986 Free article. Clinical Trial.
47 results